Nuwellis, Inc. (NUWE) stock
NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.10−0.38 (-8.48%)
Close on Nov 17, 2026Market cap $2.36MP/E –Yield –
Nuwellis price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nuwellis's price to sales ratio was 0.4× on Nov 11, 2026, against 3.7× a year earlier. Over the last 5 years it ranged from 0.0× to 5.7×, with a median of 0.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −2.3 |
| 2025 | Dec 31, 2025 | 2.6× | +0.5 |
| 2024 | Dec 31, 2024 | 2.1× | +2.0 |
| 2023 | Dec 29, 2023 | 0.0× | −0.0 |
| 2022 | Dec 30, 2022 | 0.0× | +0.0 |
| 2021 | Dec 31, 2021 | 0.0× | −47.7 |
| 2020 | Dec 31, 2020 | 47.7× | – |
See a number that looks wrong?